Difference between revisions of "Part:BBa K3142006:Design"

Latest revision as of 21:59, 20 October 2019

Milk-derived antihypertensive tripeptide（IPP）

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
COMPATIBLE WITH RFC[21]
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

Design Notes

The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.

Source

no

References

Nakano, D., K. Ogura, M. Miyakoshi, F. Ishii, et, al. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. [J] Biosci Biotechnol Biochem 2006, 70:1118–1126.

Revision as of 21:59, 20 October 2019 (view source) Xiaolin (Talk \| contribs) (→‎Design Notes) ← Older edit		Latest revision as of 21:59, 20 October 2019 (view source) Xiaolin (Talk \| contribs) (→‎References)
Line 14:		Line 14:

	===References===		===References===
		+	Nakano, D., K. Ogura, M. Miyakoshi, F. Ishii, et, al. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. [J] Biosci Biotechnol Biochem 2006, 70:1118–1126.